Dividends Calendar Earnings Calendar

PRFX | PainReform

PainReform
  • Industry: Drug Manufacturers - Specialty & Generic

Quick infos

    Trade prices

    • Volume:
    • Market Cap: 25.47M
    • Prev closed:
    • Open:
    • High:
    • Low:
    • 52 week low:
    • 52 week high:
    • Dividends:No Dividends

    Next ER: November 15, 2021 



    Top Stories (PRFX)

      Company Profile

      PainReform is a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics. Our proprietary extended release drug-delivery system has the potential to prolong the in vivo activity of APIs (active pharmaceutical ingredients), thus increasing the therapeutic window for patient treatment. Our strategy is to incorporate generic drugs with our proprietary extended release drug-delivery system in order to create extended release drug products and to take advantage of the 505(b)(2) regulatory pathway created by the U.S. Food and Drug Administration (?FDA?).

      Earnings History

      Date EPS / Forecast Revenue / Forecast
      March 17, 2022
      December 1, 2021- / -0.43- / -
      September 1, 2021- / -0.51- / -
      August 16, 2021-0.39 / -0.51- / -
      June 2, 2021-0.23 / -0.56- / -
      view more

      Historical Data

      DatePriceOpenHighLowVolChangeER
      Jan 20, 2022 1.230 1.260
      1.310
      1.230
      104.53K -3.91%
      Jan 19, 2022 1.280 1.370
      1.410
      1.210
      159.47K -5.19%
      Jan 18, 2022 1.350 1.340
      1.550
      1.300
      651.14K -2.88%
      Jan 14, 2022 1.390 1.373
      1.430
      1.372
      23.43K -1.42%
      Jan 13, 2022 1.410 1.350
      1.470
      1.350
      68.36K 2.17%
      Jan 12, 2022 1.380 1.340
      1.420
      1.340
      83.96K 0%
      Jan 11, 2022 1.380 1.355
      1.409
      1.322
      97.46K 1.47%
      Jan 10, 2022 1.360 1.310
      1.470
      1.273
      451.24K 2.26%
      Jan 7, 2022 1.330 1.360
      1.427
      1.260
      78.32K -4.32%
      Jan 6, 2022 1.390 1.410
      1.470
      1.350
      129.69K -2.11%
      view more

      This company doesn't provide a dividend.


      Talk about PainReform below in comments section below.

      Do you think you'll buy? Do you already have active trades now?

      EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
      This profile is based on publicly available information and is intended to be informative in nature.

      Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




      Other ER on Nov 15, 2021 (Same day)

      pam zyne qfin optn sndx rmed uavs api athx mark ayro bkyi 


      Jump to (Finance sites)

      Support this project

      If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
      More features coming soon :)

      Social Media 




      Recommended Books

      Investing For Dummies
      Buy on Amazon

      In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.